BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29313811)

  • 1. Imaging modalities for the diagnosis and disease activity assessment of Takayasu's arteritis: A systematic review and meta-analysis.
    Barra L; Kanji T; Malette J; Pagnoux C;
    Autoimmun Rev; 2018 Feb; 17(2):175-187. PubMed ID: 29313811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical symptoms and associated vascular imaging findings in Takayasu's arteritis compared to giant cell arteritis.
    Michailidou D; Rosenblum JS; Rimland CA; Marko J; Ahlman MA; Grayson PC
    Ann Rheum Dis; 2020 Feb; 79(2):262-267. PubMed ID: 31649025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of magnetic resonance angiography and
    Quinn KA; Ahlman MA; Malayeri AA; Marko J; Civelek AC; Rosenblum JS; Bagheri AA; Merkel PA; Novakovich E; Grayson PC
    Ann Rheum Dis; 2018 Aug; 77(8):1165-1171. PubMed ID: 29666047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An increased major vessel uptake by 18F-FDG-PET/CT in NIH criteria inactive patients with Takayasu's arteritis.
    Han Q; Liang Q; Kang F; Wang J; Wu Z; Zhu P
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):88-92. PubMed ID: 29465347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT.
    Alibaz-Oner F; Dede F; Ones T; Turoglu HT; Direskeneli H
    Mod Rheumatol; 2015 Sep; 25(5):752-5. PubMed ID: 25671403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography.
    Soriano A; Pazzola G; Boiardi L; Casali M; Muratore F; Pipitone N; Catanoso M; Aldigeri R; Cimino L; Versari A; Salvarani C
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):99-106. PubMed ID: 29799393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the diagnosis, assessment and outcome of Takayasu's arteritis.
    Alibaz-Oner F; Aydin SZ; Direskeneli H
    Clin Rheumatol; 2013 May; 32(5):541-6. PubMed ID: 23271611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis.
    Karapolat I; Kalfa M; Keser G; Yalçin M; Inal V; Kumanlioğlu K; Pirildar T; Aksu K
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S15-21. PubMed ID: 23075530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-pulseless Takayasu's arteritis evaluated with 18F-FDG positron emission tomography and gadolinium-enhanced magnetic resonance angiography.
    Meave A; Soto ME; Reyes PA; Cruz P; Talayero JA; Sierra C; Alexanderson E
    Tex Heart Inst J; 2007; 34(4):466-9. PubMed ID: 18172533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CRP value on
    Gomez L; Chaumet-Riffaud P; Noel N; Lambotte O; Goujard C; Durand E; Besson FL
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):575-581. PubMed ID: 28856429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does [18F]F-FDG-PET/MRI add metabolic information to magnetic resonance image in childhood-onset Takayasu's arteritis patients? A multicenter case series.
    Clemente G; de Souza AW; Leão Filho H; Coelho FMA; Buchpiguel C; Lima M; Carneiro C; Pereira RMR; Aikawa N; Silva CA; Campos LMA; Alves G; Astley C; Gualano B; Terreri MT
    Adv Rheumatol; 2022 Jul; 62(1):28. PubMed ID: 35879743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic complications in Takayasu's arteritis: A meta-analysis.
    Kim H; Barra L
    Semin Arthritis Rheum; 2018 Jun; 47(6):900-906. PubMed ID: 29198409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Takayasu arteritis.
    Misra DP; Singh K; Rathore U; Kavadichanda CG; Ora M; Jain N; Agarwal V
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101826. PubMed ID: 37246052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Takayasu's arteritis identified by computerized tomography: revealing the submerged portion of the iceberg?
    Zlatkin S; Aamar S; Specter G; Leibowitz D; Simanovsky N; Yeshurun D; Heyman SN
    Isr Med Assoc J; 1999 Dec; 1(4):245-9. PubMed ID: 10731353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice summary.
    Bardi M; Diamantopoulos AP
    Radiol Med; 2019 Oct; 124(10):965-972. PubMed ID: 31254221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging acquisition technique influences interpretation of positron emission tomography vascular activity in large-vessel vasculitis.
    Quinn KA; Rosenblum JS; Rimland CA; Gribbons KB; Ahlman MA; Grayson PC
    Semin Arthritis Rheum; 2020 Feb; 50(1):71-76. PubMed ID: 31375256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PET-CT with ¹⁸F-FDG in the diagnosis of Takayasu's arteritis and the assessment of response to therapy].
    Cabrera A; Caicedo AL; Elena A; Garrastachu MP; Cañete F; Ramírez R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(5):302-5. PubMed ID: 24950891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis.
    Walter MA
    Radiol Clin North Am; 2007 Jul; 45(4):735-44, viii. PubMed ID: 17706537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The feasibility of quantitative assessment of dynamic
    Duan Y; Zan K; Zhao M; Ng YL; Li H; Ge M; Chai L; Cui X; Quan W; Li K; Zhou Y; Chen L; Wang X; Cheng Z
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):81-92. PubMed ID: 37691022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of 18F-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu's arteritis.
    Quinn KA; Alessi HD; Ponte C; Rose E; Ahlman MA; Redmond C; Luo Y; Bolek EC; Langford CA; Merkel PA; Grayson PC
    Rheumatology (Oxford); 2022 Oct; 61(10):4047-4055. PubMed ID: 35022691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.